Skip to main content

Table 1 Gene significantly upregulated more than twofold in PTTG1 high MM patients

From: PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma

Probeset IDa

Gene symbol

Fisher’s p valueb

Fold changec [mean (95 % CI)]

Regulation Of cell cycle

 213226_at

CCNA2

2.20 × 10−31

2.32 (1.84–2.80)

 214710_s_at

CCNB1

2.18 × 10−40

4.07 (2.61–5.53)

 202705_at

CCNB2

1.98 × 10−41

3.54 (1.93–5.14)

 203213_at

CDK1

9.11 × 10−37

3.91 (2.44–5.39)

 1555758_a_at

CDKN3

1.63 × 10−40

2.90 (1.68–4.13)

 204170_s_at

CKS2

2.02 × 10−35

2.88 (2.69–3.07)

 218350_s_at

GMNN

1.03 × 10−32

2.32 (1.71–2.93)

 204825_at

MELK

5.20 × 10−35

2.67 (1.88–3.47)

DNA replication

 206102_at

GINS1

6.74 × 10−29

2.99 (1.91–4.07)

 202107_s_at

MCM2

1.04 × 10−33

2.33 (1.79–2.87)

 201930_at

MCM6

5.41 × 10−20

2.03 (1.32–2.74)

 201202_at

PCNA

1.74 × 10−22

2.36 (1.81–2.91)

 204127_at

RFC3

3.82 × 10−17

2.12 (1.27–2.97)

 209773_s_at

RRM2

2.80 × 10−36

4.15 (2.38–5.92)

 1554696_s_at

TYMS

7.15 × 10−41

2.47 (0.95–4.00)

Response to DNA damage

 205394_at

CHEK1

1.33 × 10−36

2.74 (1.88–3.61)

 213007_at

FANCI

2.04 × 10−24

2.25 (1.04–3.47)

 202503_s_at

KIAA0101

1.34 × 10−38

3.59 (2.23–4.96)

 223700_at

MND1

9.45 × 10−41

2.03 (1.44–2.92)

 219148_at

PBK

3.18 × 10−38

3.62 (1.60–5.64)

 205909_at

POLE2

5.33 × 10−25

2.08 (1.49–2.67)

 204146_at

RAD51AP1

2.74 × 10−26

2.41 (1.56–3.26)

 219258_at

TIPIN

2.66 × 10−33

2.06 (1.70–2.41)

 204033_at

TRIP13

4.71 × 10−38

2.45 (1.87–3.04)

Mitotic spindle and microtubule organisation

 208079_s_at

AURKA

4.49 × 10−35

2.74 (2.22–3.26)

 204162_at

NDC80

1.96 × 10−32

3.23 (1.85–4.62)

 204641_at

NEK2

1.24 × 10−29

2.84 (1.65–4.03)

 218039_at

NUSAP1

9.20 × 10−37

3.47 (1.29–5.66)

 218009_s_at

PRC1

4.37 × 10−31

2.54 (1.69–3.39)

 222077_s_at

RACGAP1

5.24 × 10−31

3.01 (1.90–4.13)

 209891_at

SPC25

3.04 × 10−40

2.84 (2.62–3.06)

 200783_s_at

STMN1

1.27 × 10−34

2.33 (1.73–2.94)

 204822_at

TTK

1.30 × 10−34

2.66 (1.03–4.28)

 204026_s_at

ZWINT

4.49 × 10−29

3.09 (1.01–5.17)

Sister chromatid segregation

 202095_s_at

BIRC5

8.63 × 10−38

2.60 (1.94–3.26)

 204962_s_at

CENPA

7.33 × 10−38

2.97 (2.14–3.81)

 231772_x_at

CENPH

2.98 × 10−32

2.12 (1.76–2.47)

 222848_at

CENPK

5.40 × 10−31

2.90 (1.86–3.94)

 219555_s_at

CENPN

1.53 × 10−33

2.06 (1.45–2.67)

 226936_at

CENPW

2.43 × 10−39

2.40 (1.39–3.41)

 218663_at

NCAPG

2.21 × 10−34

2.61 (1.44–3.79)

 213599_at

OIP5

6.22 × 10−41

2.99 (2.39–3.59)

Ubiquitin ligase activity

 202870_s_at

CDC20

1.02 × 10−36

2.43 (2.28–2.58)

 222680_s_at

DTL

4.43 × 10−29

2.88 (1.22–4.55)

 203362_s_at

MAD2L1

1.01 × 10−32

3.07 (1.92–4.23)

 202954_at

UBE2C

2.48 × 10−37

2.20 (1.15–3.24)

 223229_at

UBE2T

4.11 × 10−30

2.30 (0.82–3.78)

Chromatin modification

 203358_s_at

EZH2

1.21 × 10−24

2.41 (1.63–3.20)

 227212_s_at

PHF19

1.18 × 10−29

2.38 (1.59–3.17)

Other

 222958_s_at

DEPDC1

2.47 × 10−25

2.32 (1.31–3.32)

 226980_at

DEPDC1B

2.52 × 10−33

2.37 (2.00–2.74)

 225834_at

FAM72A/FAM72B/FAM72C/FAM72D

1.10 × 10−29

3.31 (1.01–5.62)

 228069_at

MTFR2

1.36 × 10−31

2.07 (1.62–2.53)

 235113_at

PPIL5

3.17 × 10−27

2.08 (1.53–2.63)

 229551_x_at

ZNF367

1.30 × 10−20

2.20 (1.48–2.93)

  1. aGenes are shown for which statistically significant differences were observed in all of the four datasets analysed. Data is shown for the Affymetrix probeset with the lowest p value for each gene
  2. bFisher’s method was used to combine the p values across the four datasets
  3. cMean fold change observed for PTTG1 high vs PTTG1 low patients across the four datasets